PARSIPPANY, NJ, Jan 05, 2010 (MARKETWIRE via COMTEX) -- The Medicines Company (NASDAQ: MDCO) will present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12th, in San Francisco, beginning at 2:30pm Pacific Standard Time, 5:30pm Eastern Standard Time. Clive A. Meanwell, Chairman and Chief Executive Officer, will provide a company overview and outlook in the presentation.
The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com under "Events."
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company's website is www.themedicinescompany.com.
Contact:
Robyn Brown
Vice President, Investor Relations
The Medicines Company
973-290-6000
investor.relations@themedco.com
SOURCE: The Medicines Company
mailto:investor.relations@themedco.com
